⌘K

Login Start Free

Home/Filings/4/0001493152-21-013992

4//SEC Filing

FRIEDMAN BENZION ABRAHAM 4

Accession 0001493152-21-013992

CIK 0001569340other

View on SEC.gov Company Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 1:50 PM ET

Size

26.6 KB

Accession

0001493152-21-013992

Insider Transaction Report

Form 4

Period: 2017-05-18

Cell Source, Inc.CLCS

FRIEDMAN BENZION ABRAHAM

Director10% Owner

Transactions

Other
Common Stock
2018-08-21$0.75/sh+6,672$5,004→ 4,395,416 total(indirect: See footnote)
Other
Common Stock
2017-12-04$0.75/sh+5,400$4,050→ 4,388,744 total(indirect: See footnote)
Other
Common Stock
2020-12-29$0.75/sh+19,672$14,754→ 4,471,200 total(indirect: See footnote)
Other
Common Stock
2018-12-31$0.75/sh+5,444$4,083→ 4,400,860 total(indirect: See footnote)
Other
Common Stock
2019-12-31$0.75/sh+25,675$19,256→ 4,431,891 total(indirect: See footnote)
Other
Common Stock
2020-06-30$0.75/sh+19,547$14,660→ 4,451,438 total(indirect: See footnote)
Award
Series A Convertible Preferred Stock
2017-07-26$15.00/sh+12,000$180,000→ 43,553 total(indirect: See footnote)
Exercise: $0.75From: 2017-07-26→ Common Stock (120,000 underlying)
Award
Director Stock Option (Right to Buy)
2020-08-19+300,000→ 300,000 total
Exercise: $0.75From: 2020-08-19Exp: 2025-08-19→ Common Stock (300,000 underlying)
Other
Common Stock
2019-06-26$0.75/sh+5,356$4,017→ 4,406,216 total(indirect: See footnote)
Award
Series A Convertible Preferred Stock
2019-05-07$7.50/sh+31,553$236,648→ 31,553 total(indirect: See footnote)
Exercise: $0.75From: 2019-05-07→ Common Stock (315,530 underlying)
Disposition to Issuer
Director Stock Option (Right to Buy)
2020-08-20−300,000→ 0 total
Exercise: $0.75From: 2020-08-19Exp: 2025-08-19→ Common Stock (300,000 underlying)
Award
Director Stock Option (Right to Buy)
2020-08-20+300,000→ 300,000 total(indirect: See footnote)
Exercise: $0.75From: 2020-08-19Exp: 2025-08-19→ Common Stock (300,000 underlying)

Footnotes (4)

[F1]Issued as payment-in-kind dividend on Series A Convertible Preferred Stock.
[F2]Owned by a company wholly owned by the wife of the reporting person.
[F3]The Series A Convertible Preferred Stock has no expiration date.
[F4]The reporting person was issued 12,000 shares of Series A Convertible Preferred Stock and a note in the principal amount of $180,000 for an aggregate purchase price of $180,000

Documents

1 file

4
ownership.xmlPrimary

Issuer

Cell Source, Inc.

CIK 0001569340

Entity typeother

Related Parties

1

filerCIK 0001638415

Filing Metadata

Form type: 4
Filed: Jun 9, 8:00 PM ET
Accepted: Jun 10, 1:50 PM ET
Size: 26.6 KB

View on SEC.gov